Fig. 4From: Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions(E)-3-[6-[[2-[(3-cyclopentyl-1-methyl-2-pyridin-2-ylindole-6-carbonyl)amino]-2-methylpropanoyl]amino]-2-ethoxypyridin-3-yl]prop-2-enoic acid (Template Molecule)Back to article page